Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association

J Am Coll Cardiol. 2009 Jan 20;53(3):298-304. doi: 10.1016/j.jacc.2008.10.008.

Authors

Jay S Skyler¹, Richard Bergenstal, Robert O Bonow, John Buse, Prakash Deedwania, Edwin A M Gale, Barbara V Howard, M Sue Kirkman, Mikhail Kosiborod, Peter Reaven, Robert S Sherwin; American Diabetes Association; American College of Cardiology Foundation; American Heart Association

Affiliation

¹ University of Miami, Miami, Florida.

PMID: 19147051
DOI: 10.1016/j.jacc.2008.10.008

No abstract available

Publication types

Practice Guideline
Review

MeSH terms

Blood Glucose / analysis*
Cardiovascular Diseases / prevention & control*
Diabetes Mellitus / blood
Diabetes Mellitus / drug therapy*
Diabetes Mellitus, Type 1 / diagnosis
Diabetes Mellitus, Type 1 / drug therapy
Diabetes Mellitus, Type 2 / diagnosis
Diabetes Mellitus, Type 2 / drug therapy
Diabetic Angiopathies / prevention & control
Female
Glycemic Index
Humans
Hyperglycemia / prevention & control*
Male
Randomized Controlled Trials as Topic
Risk Assessment
Sensitivity and Specificity
Survival Analysis

Substances

Blood Glucose